Literature DB >> 26701999

Patient and Technique Survival of Older Adults with ESRD Treated with Peritoneal Dialysis.

Scott D Bieber1, Rajnish Mehrotra2.   

Abstract

The number of older adults worldwide is increasing as societies gain success in improving the health and lifespan of their citizens. As a result, increasing numbers of older adults are presenting to the medical community with advanced kidney failure. Historically, dialysis treatments were withheld from older adults particularly those with severe co-existing illnesses. This has changed in most parts of the world, and there is now an increasing emphasis on shared decision-making to determine whether dialysis is appropriate and to determine which modality meets the needs, expectations, and desire of patients. Evidence examining the difference in risk for death of older adults treated with hemodialysis (HD) or peritoneal dialysis (PD), and the probability of those treated with PD to transfer to HD among older compared to younger adults, is largely derived from prospective cohort studies or analyses of data from national registries. In such studies, it is difficult to distinguish whether differences in outcomes reflect the effect of dialysis modality or differences in health status of different groups of patients. Longevity and technique survival are important, albeit not the only or most important consideration in such decision-making. Given the risk for bias in observational studies and the profound effect of dialysis modality on patients' lifestyle, the selection of dialysis modality should remain a decision made by the patient, caregivers, and his/her physician after thorough education and review of the available data.
Copyright © 2015 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Peritoneal dialysis; elderly; mortality; patient survival; survival; technique survival

Mesh:

Year:  2015        PMID: 26701999      PMCID: PMC4689460          DOI: 10.3747/pdi.2015.00050

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  35 in total

1.  Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada.

Authors:  Karen Yeates; Naisu Zhu; Edward Vonesh; Lilyanna Trpeski; Peter Blake; Stanley Fenton
Journal:  Nephrol Dial Transplant       Date:  2012-03-05       Impact factor: 5.992

2.  Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease.

Authors:  Rajnish Mehrotra; Yi-Wen Chiu; Kamyar Kalantar-Zadeh; Joanne Bargman; Edward Vonesh
Journal:  Arch Intern Med       Date:  2010-09-27

3.  Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality.

Authors:  Wai H Lim; Gursharan K Dogra; Stephen P McDonald; Fiona G Brown; David W Johnson
Journal:  Perit Dial Int       Date:  2011-05-31       Impact factor: 1.756

4.  Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States.

Authors:  Rajnish Mehrotra; Kenneth Story; Steven Guest; Michelle Fedunyszyn
Journal:  Perit Dial Int       Date:  2011-12-01       Impact factor: 1.756

5.  First-year outcomes of incident peritoneal dialysis patients in the United States.

Authors:  Joseph Pulliam; Nien-Chen Li; Franklin Maddux; Raymond Hakim; Frederic O Finkelstein; Eduardo Lacson
Journal:  Am J Kidney Dis       Date:  2014-06-11       Impact factor: 8.860

6.  Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF).

Authors:  Cindy Castrale; David Evans; Christian Verger; Emmanuel Fabre; Didier Aguilera; Jean-Philippe Ryckelynck; Thierry Lobbedez
Journal:  Nephrol Dial Transplant       Date:  2009-08-07       Impact factor: 5.992

7.  A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan.

Authors:  Yu-Kang Chang; Chih-Cheng Hsu; Shang-Jyh Hwang; Pei-Chun Chen; Chiu-Chin Huang; Tsai-Chung Li; Fung-Chang Sung
Journal:  Medicine (Baltimore)       Date:  2012-05       Impact factor: 1.889

8.  Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study.

Authors:  Mala Chidambaram; Joanne M Bargman; Robert R Quinn; Peter C Austin; Janet E Hux; Andreas Laupacis
Journal:  Perit Dial Int       Date:  2010-10-14       Impact factor: 1.756

9.  Survival of elderly dialysis patients is predicted by both patient and practice characteristics.

Authors:  Celine Foote; Toshiharu Ninomiya; Martin Gallagher; Vlado Perkovic; Alan Cass; Stephen P McDonald; Meg Jardine
Journal:  Nephrol Dial Transplant       Date:  2012-05-07       Impact factor: 5.992

10.  Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan.

Authors:  Chiu-Ching Huang; Kuang-Fu Cheng; Hong-Dar Isaac Wu
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

View more
  3 in total

1.  Transfers to Hemodialysis Among US Patients Initiating Renal Replacement Therapy With Peritoneal Dialysis.

Authors:  Rita L McGill; Daniel E Weiner; Robin Ruthazer; Dana C Miskulin; Klemens B Meyer; Eduardo Lacson
Journal:  Am J Kidney Dis       Date:  2019-07-10       Impact factor: 8.860

2.  Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A.

Authors:  Hiroki Ishii; Chiaki Miyoshi; Keiji Hirai; Junki Morino; Saori Minato; Shohei Kaneko; Katsunori Yanai; Momoko Matsuyama; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Hiroshi Shimoyama; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Yoshio Kaku; Taro Hoshino; Susumu Ookawara; Yoshiyuki Morishita
Journal:  CEN Case Rep       Date:  2020-03-16

3.  Peritoneal dialysis related infections in a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Somia M Alfayez; Shahd M Alsaqoub; Abeer Y Qattan; Mada A Alghamdi; Dalia S Elfeky; Fadel A Alrowaie; Doaa S Aljasser; Sadiqa B Syed
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.